As of July 24, 2026, Spyre Therapeutics's top three insider holders are Funds Management Llc Fairmount (Director, 4.02Mn shares), Funds Management Llc Fairmount (Director, 812.08K shares), Cameron Turtle (Chief Executive Officer, 627.54K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Jeffrey W. Albers | - | 0 | 27,360 | 08 Nov, 2024 |
| Armen Shanafelt | - | 150,000 | 0 | 13 Dec, 2021 |
| Marcio Souza | - | 90,000 | 0 | 25 Aug, 2022 |
| Cameron Turtle | Chief Executive Officer | 627,540 | 0 | 03 Apr, 2026 |
| Michael Thomas Henderson | - | 168,606 | 0 | 23 Jan, 2026 |
| Jr. Michael Conick Hanley | Chief Commercial Officer | 36,200 | 0 | 10 Jun, 2022 |
| Funds Management Llc Fairmount | - | 0 | 4,018,101 | 25 Apr, 2024 |
| Scott L Burrows | Chief Financial Officer | 97,994 | 0 | 03 Apr, 2026 |
| Jonathan Alspaugh | Chief Financial Officer | 165,372 | 0 | 15 Mar, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 01 Apr, 2026 | Scott L Burrows | Common Stock | A | 7,500 | $14.50 | 105,494 | D | M |
| 01 Apr, 2026 | Cameron Turtle | Common Stock | D | 12,344 | $49.20 | 630,196 | D | S |
| 01 Apr, 2026 | Cameron Turtle | Common Stock | D | 12,344 | $49.20 | 630,196 | D | S |
| 01 Apr, 2026 | Sheldon Sloan | Common Stock | A | 7,958 | $21.66 | 7,958 | D | M |
| 01 Apr, 2026 | Cameron Turtle | Common Stock | D | 12,344 | $49.20 | 630,196 | D | S |
| 01 Apr, 2026 | Sheldon Sloan | Common Stock | D | 7,958 | $50.00 | 0 | D | S |
| 01 Apr, 2026 | Cameron Turtle | Common Stock | D | 2,656 | $49.92 | 627,540 | D | S |
| 01 Apr, 2026 | Cameron Turtle | Common Stock | D | 2,656 | $49.92 | 627,540 | D | S |
| 01 Apr, 2026 | Cameron Turtle | Common Stock | D | 2,656 | $49.92 | 627,540 | D | S |
| 01 Apr, 2026 | Scott L Burrows | Common Stock | D | 6,200 | $49.21 | 99,294 | D | S |
| 01 Apr, 2026 | Scott L Burrows | Common Stock | D | 1,300 | $49.98 | 97,994 | D | S |
| 01 Apr, 2026 | Sheldon Sloan | Stock Option (Right to Buy) | D | 7,958 | $0.00 | 87,542 | D | M |
| 01 Apr, 2026 | Scott L Burrows | Stock Option (Right to Buy) | D | 7,500 | $0.00 | 394,857 | D | M |
| 03 Mar, 2026 | Scott L Burrows | Common Stock | A | 2,500 | $14.50 | 100,494 | D | M |
| 02 Mar, 2026 | Cameron Turtle | Common Stock | D | 5,900 | $41.73 | 651,640 | D | S |
| 02 Mar, 2026 | Cameron Turtle | Common Stock | D | 5,900 | $41.73 | 651,640 | D | S |
| 02 Mar, 2026 | Cameron Turtle | Common Stock | D | 5,900 | $41.73 | 651,640 | D | S |
| 03 Mar, 2026 | Scott L Burrows | Common Stock | D | 2,300 | $40.56 | 98,194 | D | S |
| 02 Mar, 2026 | Cameron Turtle | Common Stock | D | 9,100 | $42.49 | 642,540 | D | S |
| 02 Mar, 2026 | Cameron Turtle | Common Stock | D | 9,100 | $42.49 | 642,540 | D | S |